Winthrop Pharmaceuticals UK Ltd

One Onslow Street, Guildford, Surrey, GU1 4YS, UK
Telephone: +44 (0)1483 505 515
Fax: +44 (0)1483 554 831
E-mail: UK-medicalinformation@sanofi-aventis.com
Medical Information Direct Line: +44 (0)1483 554 101
Medical Information Fax: +44 (0)1483 554 831

Patient Information Leaflet last updated on the eMC: 12/06/2009
PIL Domperidone 1mg/ml Suspension

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 12/06/2009 and displayed until Current
Reasons for adding or updating:
  • Change to side-effects
Updated on 09/01/2009 and displayed until 12/06/2009
Reasons for adding or updating:
  • Change of trade or generic name
  • Change to Further Information section
  • Change to warnings or special precautions for use
  • Change to instructions about overdose
Updated on 22/09/2008 and displayed until 09/01/2009
Reasons for adding or updating:
  • Transfer to upgraded management system
Updated on 30/09/2004 and displayed until 22/09/2008
Reasons for adding or updating:
  • Change to, or new, use for medicine
  • Change of contra-indications
  • Change to date of revision
Updated on 06/06/2003 and displayed until 30/09/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 17/10/2002 and displayed until 06/06/2003
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but new to the eMC

Active Ingredients/Generics

 
   domperidone